Overview
This clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229\_01 at fasting state.
Eligibility
Inclusion Criteria:
- Healthy volunteers
- BMI between 18 and 30 kg/m2
- Body weight: Male ≥ 50kg, Female ≥ 45kg
- Subjects who have signed an informed consent themselves after receiving detailed explanation about clinical study
Exclusion Criteria:
- Subjects with clinically significant medical history
- Subjects with history of drug abuse or addicted
- Subjects with allergy or drug hypersensitivity